IIZUKA Akira 飯塚朗

Researcher Number	10466683
Other IDs
Affiliation (based on the past Project Information) *help	2013 – 2015: 群馬大学, 医学(系)研究科(研究院), 研究員 2011: 群馬大学, 大学院・医学系研究科, 助教 2010: 群馬大学, 大学院・医学系研究科, グローバルCOE研究員
Review Section/Research Field	Principal Investigator Neurochemistry/Neuropharmacology / Nerve anatomy/Neuropathology
Keywords	Principal Investigator プルキンエ細胞 / 脊髄小脳変性症1型 / 小脳 / 非シナプス性NMDA受容体 / 神経変性症 / 脊髄小脳変性症 / 神経変性疾患 / NMDA受容体 / メマンチン / レンチウイルスベクター … More / 回路形成 / 小脳発達 / 神経可塑性 / レンチウイルス / 遺伝子治療 Less

非シナプス性NMDA受容体に着目した脊髄小脳変性症1型の変性メカニズムの解明Principal Investigator
- Principal Investigator
  
  飯塚朗
- Project Period (FY)
  2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Neurochemistry/Neuropharmacology
- Research Institution
  Gunma University
Long-term oral administration of the NMDA receptor antagonist memantine extends life span in spinocerebellar ataxia type 1 knock-in mice.Principal Investigator
- Principal Investigator
  
  IIZUKA Akira
- Project Period (FY)
  2013 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Neurochemistry/Neuropharmacology
- Research Institution
  Gunma University
Investigation of curative effect and the neuroplasticity with the start time in the gene therapy of the cerebellar ataxic mousePrincipal Investigator
- Principal Investigator
  
  IIZUKA Akira
- Project Period (FY)
  2010 – 2011
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Nerve anatomy/Neuropathology
- Research Institution
  Gunma University

All 2015 2013 2011 Other

All Journal Article Presentation Book

[Book] Gene Therapy Applications Chapter 222011
- Author(s)
  Hirokazu Hirai, Akira Iizuka
- Data Source
  KAKENHI-PROJECT-22700374
[Book] Gene Therapy Applications Chapter 22 : (Recent Developments in Gene Therapy Research Targeted to Cerebellar Disorders)2011
- Author(s)
  Hirokazu Hirai, Akira Iizuka
- Total Pages
  22
- Publisher
  InTech
- Data Source
  KAKENHI-PROJECT-22700374
[Journal Article] Long-term oral administration of the NMDA receptor antagonist memantine extends life span in spinocerebellar ataxia type 1 knock-in mice.2015
- Author(s)
  Akira Iizuka, Kazuhiro Nakamura, Hirokazu Hirai
- Journal Title
  
  Neuroscience letters
  
  Volume: 592 Pages: 37-41
- DOI
  10.1016/j.neulet.2015.02.055
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-25830046
[Journal Article] Mesenchymal Stem Cells Ameliorate Cerebellar Pathology in a Mouse Model of Spinocerebellar Ataxia Type 1.2013
- Author(s)
  Matsuura S, Shuvaev AN, Iizuka A, Nakamura K, Hirai H.
- Journal Title
  
  Cerebellum
  
  Volume: epub Issue: 3 Pages: 323-330
- DOI
  10.1007/s12311-013-0536-1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25830046, KAKENHI-PUBLICLY-26111701
[Journal Article] Mutant PKCγ in spinocerebellar ataxia type 14 disrupts synapse elimination and long-term depression in Purkinje cells in vivo2011
- Author(s)
  Shuvaev AN, Horiuchi H, Seki T, Goenawan H, Irie T, Iizuka A, Sakai N, Hirai H
- Journal Title
  
  J Neurosci
  
  Volume: 31(40) Pages: 14324-34
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22700374
[Presentation] NMDA受容体拮抗薬メマンチンの長期経口投与によるSCA1モデルマウス病態の改善
- Author(s)
  Akira Iizuka, Kazuhiro Nakamura, Hirokazu Hirai
- Organizer
  第38回日本神経科学大会
- Place of Presentation
  神戸国際展示場
- Year and Date
  2015-07-28 – 2015-07-31
- Data Source
  KAKENHI-PROJECT-25830046

1. HIRAI Hirokazu (70291086)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
2. NAKAMURA Kazuhiro (10327835)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
3. KONNO Ayumu (40509048)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

IIZUKA Akira 飯塚 朗

Research Projects

Research Products

Co-Researchers

非シナプス性NMDA受容体に着目した脊髄小脳変性症1型の変性メカニズムの解明Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Long-term oral administration of the NMDA receptor antagonist memantine extends life span in spinocerebellar ataxia type 1 knock-in mice.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Investigation of curative effect and the neuroplasticity with the start time in the gene therapy of the cerebellar ataxic mousePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] Gene Therapy Applications Chapter 222011

Author(s)

Data Source

[Book] Gene Therapy Applications Chapter 22 : (Recent Developments in Gene Therapy Research Targeted to Cerebellar Disorders)2011

Author(s)

Total Pages

Publisher

Data Source

[Journal Article] Long-term oral administration of the NMDA receptor antagonist memantine extends life span in spinocerebellar ataxia type 1 knock-in mice.2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Mesenchymal Stem Cells Ameliorate Cerebellar Pathology in a Mouse Model of Spinocerebellar Ataxia Type 1.2013

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Mutant PKCγ in spinocerebellar ataxia type 14 disrupts synapse elimination and long-term depression in Purkinje cells in vivo2011

Author(s)

Journal Title

Data Source

[Presentation] NMDA受容体拮抗薬メマンチンの長期経口投与によるSCA1モデルマウス病態の改善

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

IIZUKA Akira 飯塚朗